Business
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue WARREN, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that the current time- and individual performance-based long-term stock incentive program will be modified to align awards with defined company milestones including reve
About this update from Tevogen Bio Holdings Inc.
[{"type":"image","alt":"Tevogen Bio Inc","displaySize":"","headline":null,"caption":"Tevogen Bio Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/5d67b8c6f92b49048a1dc80d97a6164f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kuP3e9ZLQ.FWmrA1GfPG6w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5d67b8c6f92b49048a1dc80d97a6164f","width":300,"height":157}},"lazy":false},{"type":"text","content":"Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue","length":99,"tagName":"p"},{"type":"image","alt":"Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue","displaySize":"","headline":null,"caption":"Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1200,"height":628,"url":"https://media.zenfs.com/en/globenewswire.com/9b389163b9513ff8f77d90cf143124ea"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2SdS83CElVKYYU0TUXQWUQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/9b389163b9513ff8f77d90cf143124ea","width":960,"height":502},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/EbE5viinXS277l9Zmm2V3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMjU2O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/9b389163b9513ff8f77d90cf143124ea","width":1200,"height":628}}},{"type":"text","content":"WARREN, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that the current time- and individual performance-based long-term stock incentive program will be modified to align awards with defined company milestones including revenue. The updated program will be applicable to all employees, officers, directors and consultants who are eligible to participate in the Company’s long term incentives plan.","length":473,"tagName":"p"},{"type":"text","content":"Tevogen Founder and CEO, Dr. Ryan Saadi, commented, “Tevogen began as a T cell therapy biotech and has since evolved into a diversified healthcare company, including a scalable healthcare AI initiative. The Company’s goa...